Regenerative Medical Technology Group Inc.
RMTG
$0.04
$0.003.00%
OTC PK
| 03/31/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 93.46% | 19.69% | 23.98% | 23.98% | 66.99% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 93.46% | 19.69% | 23.98% | 23.98% | 66.99% |
| Cost of Revenue | 107.64% | 183.86% | 49.29% | 49.29% | 69.52% |
| Gross Profit | 87.15% | -32.86% | 11.18% | 11.18% | 65.89% |
| SG&A Expenses | 87.23% | 33.22% | 16.76% | 16.76% | 31.83% |
| Depreciation & Amortization | 88.61% | -14.30% | -33.98% | -33.98% | -32.38% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 94.25% | 66.23% | 21.29% | 21.29% | 36.77% |
| Operating Income | 86.15% | -1,921.65% | -10.12% | -10.12% | 265.04% |
| Income Before Tax | -15.30% | -390.78% | 37.12% | 37.12% | 61.24% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -15.30% | -390.78% | 37.12% | 37.12% | 61.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.30% | -390.78% | 37.12% | 37.12% | 61.24% |
| EBIT | 86.15% | -1,921.65% | -10.12% | -10.12% | 265.04% |
| EBITDA | 86.83% | -408.04% | -44.06% | -44.06% | 3,624.53% |
| EPS Basic | -10.07% | -390.40% | 37.36% | 37.36% | 61.40% |
| Normalized Basic EPS | -10.03% | -344.12% | 37.34% | 37.34% | 61.37% |
| EPS Diluted | -10.07% | -390.40% | 37.36% | 37.36% | 61.40% |
| Normalized Diluted EPS | -10.03% | -344.12% | 37.34% | 37.34% | 61.37% |
| Average Basic Shares Outstanding | 4.79% | 0.00% | 0.36% | 0.36% | 0.36% |
| Average Diluted Shares Outstanding | 4.79% | 0.00% | 0.36% | 0.36% | 0.36% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |